<unk><unk><unk>  is recommended among patients with nonischemic dilated cardiomyopathy or ischemic heart disease at least 40 days following myocardial infarction (MI) with left ventricular ejection fraction (LVEF) of 35% and symptomatic heart failure on chronic guideline-directed medical therapy (GDMT) in order to prevent sudden cardiac death and decrease mortality.
ST elevation myocardial infarction implantable cardioverter defibrillator
ST elevation myocardial infarction coronary artery bypass grafting
ST elevation myocardial infarction aspirin therapy
ST elevation myocardial infarction calcium channel blocker therapy
ST elevation myocardial infarction reperfusion therapy
Unstable angina / non ST elevation myocardial infarction oxygen therapy
ST elevation myocardial infarction nitrate therapy
ST elevation myocardial infarction fibrinolytic therapy